Bvf Inc Bio Line Rx Ltd. Transaction History

Bvf Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.47 - $3.62 $2.48 Million - $6.1 Million	-1,686,375 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.23 - $2.39 $57,393 - $111,519	-46,661 Reduced 2.69%	1,686,375 $2.88 Million
Q3 2019 Nov 14, 2019	BUY	$2.56 - $5.25 $4.44 Million - $9.1 Million	1,733,036 New	1,733,036 $4.58 Million

852K

Ticker BLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,524,500
Market Cap $192M
Description
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.